Operation Epic Fury

U.S. Central Command (CENTCOM) commenced Operation Epic Fury at the direction of the President of the United States. CENTCOM forces are striking targets to dismantle the Iranian regime's security apparatus, prioritizing locations that pose an imminent threat.

Operation Epic Fury Fact Sheet

Operation Epic Fury Videos

Video by Courtesy

Putting SARS-COV-2 in a Bind

Defense Threat Reduction Agency's Chemical and Biological Technologies Department

Feb. 1, 2022 | 1:09

Nanosponges are tiny biodegradable polymers wrapped by the membrane of target cells, such as lung epithelial cells. These novel nanosponges could potentially combat a variety of viruses that enter hosts' airways by acting as a decoy and binding to the viruses before they can bind to host cells.

Zhang et al. recently published results showing that SARS-CoV-2 binds to these decoy nanosponges that were more than 90% effective in causing the virus to lose its ability to infect cells in vitro. Once the virus is locked into the decoy, it can't invade any real cells, and is then cleared by the body's immune system. UCSD researchers specifically focused on overexpressing ACE-2, the key player mediating the entry of SARS-CoV-2.

This research shows promise that nanosponges could be used both to prevent disease and as a post-exposure treatment to better protect warfighters and the public from COVID-19 and other emerging infectious diseases.

Up Next

Now Playing

Putting SARS-COV-2 in a Bind